The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 243-246

  Bowes, Susan B ^a   Umpleby, Margot ^a   Cummings, Michael H ^a   Jackson, Nicola C ^a   Carroll, Paul V ^a   Lowy, Clara ^a   Sönksen, Peter H ^a   Russell Jones, David L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEUCINE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CUSHING DISEASE; FEMALE; GLUCOSE METABOLISM; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE ATROPHY; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CUSHING SYNDROME; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEUCINE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 0031032143     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.1.243     Document Type: Article

References (34)

1. Ross EJ, Linch DC. 1982 Cushing's syndrome-killing disease. Discriminatory values of signs and symptoms aiding early diagnosis. Lancet 2:646-649.
2. Lamberts SWJ, Birkenhager JC. 1976 Body composition in Cushing's disease. J Clin Endocrinol Metab. 42:864-868.
3. Bowes SB, Benn JJ, Scobie IN, Umpleby AM, Lowy C, Sönksen PH. 1993 Leucine metabolism in patients with Cushing's syndrome before and after successful treatment. Clin Endocrinol (Oxf). 39:591-598.
4. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. 1993 The effects of growth hormone on protein metabolism in growth hormone deficient patients. Clin Endocrinol (Oxf). 38:427-431.
5. Horber FF, Haymond MW. 1990 Human growth hormone prevents the protein catabolic effects of prednisone in humans. J Clin Invest. 86:265-272.
6. Bennet WM, Haymond MW. 1992 Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol (Oxf). 36:161-164.
7. Sherwin RS, Shulman GA, Hendler R, Walesky AB, Belous A, Tamborlane W. 1983 Effects of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia. 24:155-161.
8. 13C KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectom. 128:432-436.
9. Weicko J, Sherman WR. 1976 Boroacetylation of carbohydrates. Correlations between structure and mass spectral behaviour in monoacetylhexose cyclic boronic esters. J Am Chem Soc. 98:7631-7637.
10. Sönksen PH. 1976 Double antibody technique for the simultaneous assay of insulin and growth hormone. In: Antoniades H, ed. Hormones in human blood: detection and assay. Cambridge: Harvard University Press; 176-199.
11. Brooks RV, Dupre J, Gogate AN, Mills IH, Prunty FTG. 1963 Appraisal of adrenocortical hyperfunction: patients with Cushing's syndrome or non-endocrine tumours. J Clin Endocrinol Metab. 23:725-736.
12. Teale JD, Marks V. 1990 Inappropriately elevated plasma IGF-II in relation to suppressed IGF-I in the diagnosis of non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf). 33:87-98.
13. 13C leucine. Am J Physiol 238:E473-E479.
14. 13C]leucine infusion in man: a method for measuring human intracellular leucine tracer environment. Metab Clin Exp. 31:1105-1112.
15. Bang P, Degerblad M, Thoren M, Schwander J, Blum W, Hall K. 1993 Insulin like growth factor III and IGF binding protein (IGFBP) 1,2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol (Copenh). 128:397-404.
16. Frantz AG, Rabkin MT. 1964 Human growth hormone, clinical measurement, response to hypoglycaemia and suppression by corticosteroids. N Engl J Med. 271:1375.
17. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. 1994 Inhibition of growth hormone release after administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol (Oxf). 41:649-654.
18. Daughaday WH, Phillips LS, Mueller M. 1976 The effects of insulin and GH on the release of somatomedin by the isolated rat liver. Endocrinology. 98:1214-1220.
19. Böni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. 1991 Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 260:E846-E851.
20. Sherwin RS, Schulman GA, Hendler R, Walesky M, Belous A, Tamborlane W. 1983 Effect of GH on glucose tolerance and circulating metabolic fuels in man. Diabetologia. 24:155-161.
21. Castellino P, Luzi L, Simonson DC, Haymond MW, DeFronzo RA. 1987 Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. J Clin Invest. 80:1784-1793.
22. Loftfield RB, Harris A. 1956 Participation of free amino acids in protein synthesis. J Biol Chem. 219:151-159.
23. Turkalji I, Keller U, Ninnis R, Vosmeer S, Stauffacher W. 1992 Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid and leucine metabolism in man. J Clin Endocrinol Metab. 75:1186-1191.
24. Umpleby AM, Shojaee-Moradie F, Thomason MJ, et al. 1994 Effects of insulin-like growth factor-i (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs. J Clin Invest. 24:337-344.
25. Russell-Jones DL, Umpleby AM, Hennessy TR, et al. 1994 Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 267:E591-E598.
26. Inoue Y, Copeland EM, Souba WW. 1994 Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg. 219:715-722.
27. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sonksen PH. 1986 The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia. 29:131-141.
28. Tessari P, Trevisan R, Inchiostro S, et al. 1986 Dose response curves of effects of insulin on leucine kinetics in humans. Am J Physiol 251:E334-E342.
29. Fryburg DA, Gefland RA, Barrett EJ. 1991 Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 260:E499-E504.
30. Lehner JH, Jauch KW, Berger G, Tacke J, Savic B. 1992 A multicentre study of the dose response effect of human recombinant GH on cumulative nitrogen balance in patients after major abdominal surgery. Ann Surg. 208:6-16.
31. Wilmore DW, Moylan JA, Bristow BF, Mason AD, Pruitt BA. 1974 Anabolic effects of growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet. 138:875-884.
32. Ziegler TR, Young LS, Ferrari-Baliviera E, Demlind RH, Wilmore DW. 1990 Use of hGH combined with nutritional support in a critical care unit J Parenter Enteral Nutr. 14:574-581.
33. Krentz AJ, Koster FT, Crist DM, et al. 1993 Anthropometric, metabolic and immunological effects of recombinant human GH in AIDS and AIDS-related complex. J Acquired Immune Deficiency Syndrome. 6:245-251.
34. Giustina A, Bussi AR, Jacobello C, Wehrenberg WB. 1995 Effects of recombinant human GH on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH releasing hormone. J Clin Endocrinol Metab. 80:122-129.